jia-luo.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

Thank you Drs Aggarwal, Bunn, Neal, Reckamp, and @iaslc.bsky.social for the invitation and hosting a fantastic inaugural #TTLC25 meeting in HB! 🍊 Feeling refreshed, energized, and inspired in research, patient care, and advocacy

submitted 6 days ago • 0 comments

Thank you, Dr Florez, for inviting us to record LIVE from #TTLC25 🍊 Fantastic discussions with you and Dr Melina Marmarelis www.iaslc.org/iaslc-news/l...

submitted 6 days ago • 0 comments

Great summary of data to date on neo-IO/IO/chemo combos in NSCLC by Dr Jamie Chaft #TTLC25 @iaslc.bsky.social #lcsm

submitted 6 days ago • 0 comments

Great talk by @jia-luo.bsky.social from @danafarber.bsky.social at #TTLC25 talking about NUT carcinoma also highlights recent review www.nature.com/articles/s41...

submitted 7 days ago • 1 comment

Important poster presented at #TTLC25 by @jessieross.bsky.social and Alissa Cooper from @mskcancercenter.bsky.social on overlap of DLL3/SEZ6 in high grade neuroendocrine cancers

submitted 7 days ago • 0 comments

Excellent talk and framework on the approach to targeted therapies for neuroendocrine tumors by Dr Nathaniel Myall #TTLC25 #lcsm @iaslc.bsky.social

submitted 7 days ago • 0 comments

Dr Mehmet Altan presenting on targeted therapies in clinical trials for thymic malignancies, emphasizing the importance of multicenter collaboration in this cancer #TTLC25 #lcsm @iaslc.bsky.social

submitted 7 days ago • 0 comments

Excellent summary of targeted therapies in clinical trials for mesothelioma, a thoracic malignancy without approved targeted agents by Dr Melina Marmarelis #TTLC25 @iaslc.bsky.social #lcsm

submitted 7 days ago • 0 comments

Great to see that one of the inspirational leaders in our field, Dr Ravi Salgia, is well at @iaslc.bsky.social #TTLC25 and thoughts are with those in the community affected by the recent fires in LA people.com/doctor-famil... #lcsm #oncsky

submitted 7 days ago • 0 comments

Wonderful talk brimming with words of wisdom by Dr Heather Wakelee at the @iaslc.bsky.social #TTLC25 faculty dinner

submitted 7 days ago • 0 comments

So wonderful to catch up with the thoughtful and aspirational investigator, Dr Liza Villaruz - looking forward to all that we do for our patients with NSCLC and NUT carcinoma 🙏🏻

submitted 7 days ago • 0 comments

🌟 Justin Kim (MD-to-be) and Sara Walton (MPH student) presenting on the defining features of NUT carcinoma at #TTLC25 #lcsm #oncsky 🙏🏻 to our collaborators on this effort

submitted 7 days ago • 0 comments

Great and well-researched debate by Drs Jessica Lin and Jared Weiss - should TKIs be moved to the adjuvant setting? #TTLC25 @iaslc.bsky.social #lcsm

submitted 7 days ago • 0 comments

Excellent presentation by Dr Rebecca Heist on the nuances of bringing KRAS G12C inhibitors into the 1L #TTLC25 @iaslc.bsky.social #lcsm

submitted 7 days ago • 0 comments

Excellent overview of BRAFmt lung cancer biology, comparison of approved combinations, and overview of several interesting compounds in development by Dr Kathryn Arbour @iaslc.bsky.social #lcsm #TTLC25

submitted 8 days ago • 0 comments

Targeted Therapies of Lung Cancer meeting 2025. Huntington Beach, California. Fish are fun, cherubs are wierd

submitted 8 days ago • 1 comment

Exciting presentations by Drs Michael Cheng, Hina Khan, and Ramaswamy Govindan at #TTLC25 on new RAS inhibitors in development in thoracic cancers #lcsm #oncsky @iaslc.bsky.social

submitted 8 days ago • 1 comment

Lively (post 6p!) debate on potential role of ADCs in NSCLC by colleague Dr Jacob Sands and Dr Rachel Sanborn #TTLC25 @danafarber.bsky.social #lcsm #oncsky

submitted 8 days ago • 0 comments

Fantastic comprehensive talk on role of consolidative radiation in lung cancer treatment by colleague Dr David Kozono Great discussion regarding existing data including PORT and ongoing trials - and subsequent Q&A! @danafarber.bsky.social #lcsm #oncsky @iaslc.bsky.social

submitted 8 days ago • 0 comments

Excellent and entertaining debate at #TTLC25 on the best 1L therapy for EGFR NSCLC by Drs Helena Yu and Shirish Gadgeel Multiple considerations including baseline factors and patient centered shared decision making whether to add chemo to osimertinib #lcsm #oncsky @iaslc.bsky.social

submitted 8 days ago • 0 comments

Excellent summary of the approach to uncommon EGFR mutations by Dr Xiuning Le (MDACC) #TTLC25 #lcsm #oncsky @iaslc.bsky.social

submitted 9 days ago • 0 comments

Packed room at #TTLC25 and fantastic intro talk to EGFR therapy sequencing and unanswered questions by my colleague Dr Julia Rotow #lcsm #oncsky @danafarber.bsky.social @iaslc.bsky.social

submitted 9 days ago • 1 comment

Clear and thoughtful FAQ by DFCI colleague Sasha Gusev on the recent NIH and NSF grant cuts - highly recommended reading! #medsky #oncsky

submitted 9 days ago • 0 comments

The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. Read our statement: https://buff.ly/4gRXNB8

submitted 10 days ago • 3 comments

"Ms. Baldwin said in a statement[...] 'Make no mistake, their efforts to rob Peter to pay Paul means crushing families’ hopes and dreams of having cures.'[...] The NIH has undergone considerable turmoil in recent days, with two high-ranking officials announcing sudden departures." #oncsky #medsky

submitted 14 days ago • 0 comments

US science is under attack ‘Americans who value the spirit of discovery — and eagerly await new ways to confront disease, strengthen our economy and improve the quality of human life — need to issue a strong outcry.’ www.nytimes.com/2025/02/14/o...

submitted 15 days ago • 0 comments

IASLC #WCLC2025 is upon us! Your co-chairs cannot wait to welcome you #NoemiReguart 🇪🇸 #IsabelleOpitz🇨🇭 #UmbertoMalapelle 🇮🇹 & a familiar face from🇮🇪 Registration & abstract submissions are OPEN! Join us in Barcelona | Sept 6–9, 2025 @iaslc.bsky.social @oncoalert.bsky.social #LCSM bit.ly/IASLCWCLC

submitted 15 days ago • 0 comments

1/ Why this is🚨? My colleagues, collaborators, and I are funded by #NIH to bring the most promising medicines to people with life-threatening illness How does this work? www.science.org/content/arti... #oncsky #lcsm

submitted 21 days ago • 1 comment

Research universities are often the largest employers in their region. They are often the primary health care providers to communities. This funding shift will not only reduce US research leadership, it will put working people out of work and reduce healthcare access.

submitted 21 days ago • 105 comments

"This moment is a test. How should our community react? The immediate result has been confusion, disruption, and disorientation, but the response cannot be dictated by fear or resignation. There is a need for focus, strategy, and—indeed—hope"

submitted 22 days ago • 2 comments

Moving defense of childhood #vaccines by Vanderbilt vaccine expert Kathy Edwards in JAMA. Stunning that so many people fear the tools that prevent children from dying and being maimed, rather than the pathogens that resurge when vaccine use declines. jamanetwork.com/journals/jam...

submitted 22 days ago • 7 comments

Awesome presentation run throughs for IASLC TTLC 2025 with this talented crew Looks like a great program by the Conference Chairs (www.ttlc2025-iaslc.org/full-program) - cya in So Cal in 2 weeks! 🍊 @danafarber.bsky.social @danafarbernews.bsky.social @iaslc.bsky.social #lcsm #oncsky #TTLC25

submitted 22 days ago • 1 comment

Helpful note: if the DC office isn't picking up, you can also call your reps' local offices. Per another user, "Tap the dots to right of the DC number and local office numbers come up."

submitted 23 days ago • 2 comments

Amp up your lung cancer patient advocacy! Apply for the STARS Program Take steps to amp up your lung cancer patient advocacy! Applications are now open for the 2025 IASLC STARS PRA & Scholar Programs. STARS (Supportive Training for Advocates on Research and Science) can help you develop and…

submitted 25 days ago • 1 comment

🌟 In Nature Reviews Clinical Oncology, we examine the overwhelming evidence for classifying NUT carcinoma as a subtype of squamous lung cancer and squamous head and neck cancer 🫁 🗣️ rdcu.be/d8uni @natrevclinoncol.bsky.social #medsky #oncsky #meded #lcsm #lungcancer 🧵 Highlights:

submitted 25 days ago • 1 comment

submitted 25 days ago • 0 comments